Choosing the best approach for patients with favorable-risk metastatic renal cell carcinoma.
Publication
, Journal Article
Zhang, T; George, DJ
Published in: Clin Adv Hematol Oncol
April 2020
Duke Scholars
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
April 2020
Volume
18
Issue
4
Start / End Page
204 / 207
Location
United States
Related Subject Headings
- Risk Factors
- Oncology & Carcinogenesis
- Neoplasm Metastasis
- Kidney Neoplasms
- Humans
- Carcinoma, Renal Cell
- Antineoplastic Combined Chemotherapy Protocols
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhang, T., & George, D. J. (2020). Choosing the best approach for patients with favorable-risk metastatic renal cell carcinoma. Clin Adv Hematol Oncol, 18(4), 204–207.
Zhang, Tian, and Daniel J. George. “Choosing the best approach for patients with favorable-risk metastatic renal cell carcinoma.” Clin Adv Hematol Oncol 18, no. 4 (April 2020): 204–7.
Zhang T, George DJ. Choosing the best approach for patients with favorable-risk metastatic renal cell carcinoma. Clin Adv Hematol Oncol. 2020 Apr;18(4):204–7.
Zhang, Tian, and Daniel J. George. “Choosing the best approach for patients with favorable-risk metastatic renal cell carcinoma.” Clin Adv Hematol Oncol, vol. 18, no. 4, Apr. 2020, pp. 204–07.
Zhang T, George DJ. Choosing the best approach for patients with favorable-risk metastatic renal cell carcinoma. Clin Adv Hematol Oncol. 2020 Apr;18(4):204–207.
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
April 2020
Volume
18
Issue
4
Start / End Page
204 / 207
Location
United States
Related Subject Headings
- Risk Factors
- Oncology & Carcinogenesis
- Neoplasm Metastasis
- Kidney Neoplasms
- Humans
- Carcinoma, Renal Cell
- Antineoplastic Combined Chemotherapy Protocols